Girish Kirimanjeswara | Veterinary and Biomedical Science
Eva J. Pell ABSL-3 Laboratory for Advanced Biological Research (Pell Lab) has been playing a key role in Penn State’s response to emerging infectious diseases. With a unique combination of in vitro, insect, and animal research capabilities, Pell lab has played a key role in responding to Avian Influenza in 2015, Zika virus crisis in 2016-17, and the current COVID-19 pandemic. With several academic and industry partnerships, current investigations include diagnostics, ant-viral drug discovery, animal models of disease, and host responses to SARS-CoV-2. We are also facilitating surface testing and validation of sterilization methods using various corona virus surrogates and SARS-CoV-2. My talk will briefly introduce Pell lab, describe the ongoing COVID-19 research, and discuss potential opportunities for collaborations.